News

WUHAN, June 12 (Xinhua) -- A China-developed cutting-edge cancer detection device, which integrates positron emission tomography (PET) scan and CT scan, has been approved by national drug regulators and obtained market access earlier this month.The equipment was developed by scientists from the Huazhong University of Science and Technology based in Wuhan, Hubei Province, after a 19-year study.I...

All is not lostChen Jiayuan is participating in a trial involving patients with myeloma, a form of bone marrow cancer. Chimeric antigen receptor cell therapy, or CAR-T, works by hacking the body's biology. Though it's not yet officially approved in China, she believes it's her last chance.CAR-T is at the cutting edge of biomedicine. It's an opportunity for China to advance to the forefront of t...

BEIJING, May 7 (Xinhua) -- The first China-developed digital positron emission tomography (PET) scan is undergoing clinical trials, according to its developer, China's Huazhong University of Science and Technology.PET scans are one of the most sophisticated medical imaging devices. Compared with other medical imaging methods such as CT scans, X-rays and magnetic resonance imaging (MRI), PET has...